Emilie Poirion1, Corentine Marie2, Marine Boudot de La Motte3, Chloé Dupont4, Jean-Claude Sadik1, and Julien Savatovsky1
1Hospital Foundation A. de Rothschild, Imaging department, Paris, France, PARIS, France, 2Sorbonne University, Paris Brain Institute, Paris, France, Paris, France, 3Hospital Foundation Rothschild,Neurology department, Paris, France, Paris, France, 4Hospital Foundation A. de Rothschild, Pharmaceutical department, Paris, France, PARIS, France
Synopsis
Gadolinium-enhanced
imaging provides valuable information in clinical practice for the diagnosis of
several diseases. Conventional sequences fail to detect low concentrations of
gadolinium, such as those encountered in abnormal meninges. We designed a
phantom containing 16 diluted gadobutrol tubes to compare and optimize sequences,
based on normalized signal and contrast-to-noise ratio, for each gadolinium
concentration. We performed a preliminary study comparing T1, FLAIR and FLAIR
with optimized parameters on this phantom.
The
optimized FLAIR sequence shows an efficient detection of low concentrations,
with a higher CNR than other sequences. Preliminary in-vivo experiment shows
promising results for leptomeningeal abnomalities detection.
Introduction
Gadolinium-based
contrast agents provide valuable information in clinical practice, and intravenous
injection before or during MR imaging is often required. Indeed, many CNS
disorders, such as Multiple Sclerosis (MS) [1], require intravenous injection of gadolinium (Gd) to be detected or assessed. However, due to recent evidences of gadolinium
deposition in the brain [2], clinical strategies to reduce lifespan
exposure to gadolinium in patients requiring repeated scans are developed. Among
them, developing sequences with improved sensitivity to lower gadolinium
concentrations would allow to reduce the required injected dose to reach the
diagnosis.
It is proven
that 3-dimensional fluid-attenuated inversion recovery (FLAIR) has a higher
sensitivity than T1-weighted (T1-w) imaging to detect low concentrations of Gd.
In MS, this sequence is efficient to detect leptomeningeal enhancement from extravasation
of gadolinium in the meninges [3], [4]. However, in some patients, meningeal
Gd concentration is too low to be detected with FLAIR sequences. The modification
of refocusing angle schemes might reduce the signal of the normal brain
parenchyma, and increase the signal of small gadolinium concentration contents in
sulci.
This project aims to evaluate whether the
optimized FLAIR could detect lower dose of Gd than classical FLAIR and T1w
sequences after intravenous Gd administration.Methods
Phantom study
We designed
a phantom using 16 conical tubes of 50mL filled with diluted gadobutrol and
saline, in a 1% agarose gel solution in a 5 L plastic container (Figure 1). The
original Gd (1.0mmol/mL solution) was diluted with saline to a reference
concentration at 1.152mg/ml that simulate the concentration of gadolinium in
the brain CSF, within the first 8 hours after intravenous injection. Dilutions range from x3 to 1/2
000 000 of the theoretical concentration of the extravasated gadolinium.
The phantom
was scanned on a 3-tesla MR system (Ingenia, Philips) using a 32-channel array
head coil. Imaging protocol included the following sequences (Figure 2A-D): T1-w
TFE (TR/TE=8.0/3.5ms, resolution = 1x1x1mm3), T1 TSE
(TR/TE=500/27ms, resolution = 1x1x1mm3), FLAIR (TR/TE/TI=8000/400/2400ms,
resolution = 1x1x1mm3), and an optimized FLAIR with the same MR
parameters than conventional FLAIR but a modified refocusing angles scheme.
Each tube
was segmented and labeled using an in-house tool on the T1 TFE sequence (Figure
2E), and the mean and standard deviation of MR signal was measured over 6
continuous slices. The mean signal of each tube was then normalized to the
saline tube. Contrast-to-noise ratio (CNR) was computed between saline and
fluid with diluted Gd, defining noise as the standard deviation (SD) of the
region of interest (ROI) in the saline tube (SDsaline). We
calculated CNR as the difference between the signal intensity of the
Gd-containing tubes (SIGd) and saline (SIsaline), divided
by SDsaline from, as follow:
$$CNR = | SIGd-SIsaline|/SDsaline$$.
In-vivo study
As all
sequences performed on the phantom are part of the clinical routine for MS
follow-up, a qualitative evaluation was performed on a patient with MS. The
clinical follow-up includes similar sequences to phantom MR protocol: T1 TSE,
FLAIR and optimized FLAIR. Results
Phantom study
Figure 3A
shows the normalized mean signal of the three sequences from six slices in each
diluted solution. In all sequences, the normalized mean signal globally increases
with increasing concentration of gadolinium. For gadolinium doses inferior at
1/10, the optimized FLAIR has a higher normalized mean signal compared to the
T1 TSE sequence, relative to the saline reference. The optimized FLAIR has a
higher normalized mean signal than the conventional FLAIR for doses superior to
1/100. However, while the optimized FLAIR has not a higher normalized mean
signal for very low gadolinium concentration (<1/100), the CNR of the
optimized FLAIR is higher for low dose (>1/100; mean CNRoptimized FLAIR
= 1.86, CNRFLAIR=1.24, respectively) and as good as the one
of the conventional FLAIR for very low dose (>1/1 000 000; CNRoptimized
FLAIR = 0.47, CNRFLAIR=0.24, respectively).
In-vivo study: preliminary
results
Following
results on the phantom, suggesting that the optimized FLAIR might be effective
to detect low doses of extravagated Gd, we reviewed sequences from a patient
with MS (female, 31Y) on whom the 3 sequences have been performed. A linear
leptomeningeal enhancement was visible (Figure 4) only visible on the optimized
FLAIR, due to both brain and cerebrospinal fluid suppression.Discussion
In this
study, we present a customized phantom that can be used to assess the performances
of various sequences and parameters to detect low-Gd concentrations. We use
that tool to demonstrate that the FLAIR sequence can be made more sensitive to
subtle gadolinium enhancements by modifying refocusing angle schemes. While
signal intensity decreases with decreasing Gd concentration for all sequences, optimized
FLAIR sequence offers a higher CNR than other sequences showing its interest to
detect very low doses of Gd (expressed as mg/ml). This higher CNR might improve
the sensitivity to detect subtle extravagated Gd in the meninges, which is highlighted
in several pathologies, such as Multiple Sclerosis.
However,
the drop of signal for high concentration that is visible for IR sequence might
be due to suboptimal MR parameters, and some new experiments are needed varying
the repetition time (and its corresponding inversion time) or the refocusing
angle schemes, to fully describe the signal evolution of the optimized FLAIR
sequence.Acknowledgements
No acknowledgement found.References
[1] A.
J. Thompson et al., « Diagnosis of multiple sclerosis: 2017
revisions of the McDonald criteria », Lancet Neurol., vol. 17, no
2, p. 162‑173, févr. 2018, doi: 10.1016/S1474-4422(17)30470-2.
[2] R. J. McDonald et al., « Intracranial
Gadolinium Deposition after Contrast-enhanced MR Imaging », Radiology,
vol. 275, no 3, p. 772‑782, mars 2015,
doi: 10.1148/radiol.15150025.
[3] P. Eisele et al.,
« Investigation of leptomeningeal enhancement in MS: a postcontrast FLAIR
MRI study », Neurology, vol. 84, no 8, p. 770‑775, févr. 2015, doi:
10.1212/WNL.0000000000001286.
[4] M. Absinta et al.,
« Gadolinium-based MRI characterization of leptomeningeal inflammation in
multiple sclerosis », Neurology, vol. 85, no 1, p. 18‑28, juill. 2015, doi: 10.1212/WNL.0000000000001587.
[5] F. Berger et al.,
« Gadolinium distribution in cerebrospinal fluid after administration of a
gadolinium-based MR contrast agent in humans », Radiology, vol.
288, no 3, p. 703–709, 2018.